` MIR (MedMira Inc) vs S&P TSX Composite Index (Canada) Comparison - Alpha Spread

MIR
vs
S&P TSX Composite Index (Canada)

Over the past 12 months, MIR has underperformed S&P TSX Composite Index (Canada), delivering a return of 13% compared to the S&P TSX Composite Index (Canada)'s 13% growth.

Stocks Performance
MIR vs S&P TSX Composite Index (Canada)

Loading
MIR
S&P TSX Composite Index (Canada)
Add Stock

Performance Gap
MIR vs S&P TSX Composite Index (Canada)

Sign Up to see
Performance Gap
Sign In
Sign Up

Performance By Year
MIR vs S&P TSX Composite Index (Canada)

Loading
MIR
S&P TSX Composite Index (Canada)
Add Stock

Competitors Performance
MedMira Inc vs Peers

S&P TSX Composite Index (Canada)
MIR
ABT
ISRG
BSX
SYK
Add Stock

MedMira Inc
Glance View

Market Cap
63.2m CAD
Industry
Health Care

MedMira, Inc. is a biotechnology company, which through its subsidiaries, engages in the research, development, manufacture, and commercialization of diagnostics and technology platforms. The company is headquartered in Halifax, Nova Scotia. The firm is engaged in the development and commercialization of rapid diagnostics and technology platforms. The MedMira Rapid Vertical Flow (RVF) Technology platform is the basis for the Company's line of rapid tests. Its technology platform detects multiple biomarkers specific to several diseases using a single cartridge. Its Multiplo line of rapid tests for human immunodeficiency virus (HIV), Hepatitis B and C, and syphilis uses the platforms capabilities to deliver approximately up to four test results using one test cartridge and one drop of specimen. The company also has a research product line that facilitates technology licensing, contract manufacturing, and regulatory consulting. The firm sells its rapid tests through a network of medical distributors and strategic business development partners to customers in all sectors of the healthcare industry, including laboratories, hospitals and point-of-care clinics, among others.

MIR Intrinsic Value
HIDDEN
Show
Back to Top